Stockreport

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]

Verve Therapeutics, Inc.  (VERV) 
PDF cardiovascular disease with single-course gene editing medicines, today announced that on February 29, 2024, the company granted equity awards to three new employees, pu [Read more]